Stereoselective synthesis of C3-C12 dihydropyran portion of antitumor laulimalide using copper-catalyzed oxonium ylide formation-[2,3] shift

Takayuki Yakura*, Wataru Muramatsu, Jun'ichi Uenishi

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

Copper-catalyzed oxonium ylide formation-[2,3] shift of (5S,7R)-5-allyloxy-1-diazo-8-(p-methoxybenzyloxy)-7-methyl-2-octanone (3) proceeded in tetrahydrofuran-dichloromethane (4 : 1) under reflux with an excellent stereoselectivity (97 : 3) to give (2R,6S)-2-allyl-6-[(2R)-3-(p- methoxybenzyloxy)-2-methylpropyl]-3-dihydropyranone (2) as a major isomer in 82% yield. The resultant pyranone (2) was converted to the key intermediate (1) of the Mulzer's laulimalide synthesis and its derivatives (14, 15).

Original languageEnglish
Pages (from-to)989-994
Number of pages6
JournalChemical and Pharmaceutical Bulletin
Volume53
Issue number8
DOIs
StatePublished - 2005/08

Keywords

  • 3-pyranone
  • Antitumor
  • Copper catalyst
  • Laulimalide
  • Oxonium ylide
  • [2,3] shift

ASJC Scopus subject areas

  • General Chemistry
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Stereoselective synthesis of C3-C12 dihydropyran portion of antitumor laulimalide using copper-catalyzed oxonium ylide formation-[2,3] shift'. Together they form a unique fingerprint.

Cite this